Rchr
J-GLOBAL ID：202301014771872998
Update date: Mar. 07, 2024
Watari Shogo
ワタリ ショウゴ | Watari Shogo
Affiliation and department：
Research theme for competitive and other funds (2)：
- 2021 - 2025 尿路感染におけるHMGB1の動態解析と尿中特異マーカーの可能性に関する探索的研究
- 2019 - 2022 Study for application of Diamond-like carbon to indwelling urinary catheters
Papers (17)：
-
Shogo Watari, Satoshi Katayama, Hiromasa Shiraishi, Moto Tokunaga, Risa Kubota, Norihiro Kusumi, Takaharu Ichikawa, Tomoyasu Tsushima, Yasuyuki Kobayashi, Kensuke Bekku, et al. Geriatric nutritional risk index as a prognostic marker of first-line immune checkpoint inhibitor combination therapy in patients with renal cell carcinoma: a retrospective multi-center study. Discover. Oncology. 2023. 14. 1. 204-204
-
Jun Matsumoto, Anzu Nishimoto, Shogo Watari, Hideo Ueki, Shoya Shiromizu, Naohiro Iwata, Tatsuaki Takeda, Soichiro Ushio, Makoto Kajizono, Masachika Fujiyoshi, et al. Significance of UGT1A6, UGT1A9, and UGT2B7 genetic variants and their mRNA expression in the clinical outcome of renal cell carcinoma. Molecular and cellular biochemistry. 2023. 478. 8. 1779-1790
-
Shogo Watari, Takaharu Ichikawa, Hiromasa Shiraishi, Moto Tokunaga, Risa Kubota, Norihiro Kusumi, Tomoyasu Tsushima. Efficacy of urine loss ratio for prognosis of urinary continence after radical prostatectomy: A retrospective cohort study in a single Japanese institution. Investigative and clinical urology. 2023. 64. 2. 168-174
-
Jun Matsumoto, Naohiro Iwata, Shogo Watari, Soichiro Ushio, Shoya Shiromizu, Tatsuaki Takeda, Hirofumi Hamano, Makoto Kajizono, Motoo Araki, Yasutomo Nasu, et al. Adverse Events of Axitinib plus Pembrolizumab Versus Lenvatinib plus Pembrolizumab: A Pharmacovigilance Study in Food and Drug Administration Adverse Event Reporting System. European urology focus. 2023. 9. 1. 141-144
-
Shogo Watari, Takaharu Ichikawa, Hiromasa Shiraishi, Takafumi Sakuma, Risa Kubota, Norihiro Kusumi, Tomoyasu Tsushima, Keina Nagakita, Yoko Shinno. Retroperitoneal myofibroblastoma in an 88-year-old male. IJU case reports. 2022. 5. 5. 378-382
ｍore...
MISC (90)：
-
関戸 崇了, 白石 裕雅, 徳永 素, 和田里 章悟, 久住 倫宏, 市川 孝治, 津島 知靖. 高位鎖肛術後の尿道狭窄に対して尿道形成術を施行した1例. 西日本泌尿器科. 2023. 85. 増刊号2. 148-148
-
久住 倫宏, 白石 裕雅, 和田里 章悟, 佐久間 貴文, 窪田 理沙, 津島 知靖, 市川 孝治. 当院での腹腔鏡下腎部分切除術の検討 核出術と切除術との比較. Japanese Journal of Endourology and Robotics. 2023. 36. 1. 129-134
-
和田里 章悟, 市川 孝治, 平沢 晃, 白石 裕雅, 徳永 素, 窪田 理沙, 久住 倫宏, 津島 知靖, 神農 陽子, 古屋 充子. Birt-Hogg-Dube症候群の家系員への介入が可能になった一例. 日本泌尿器科学会雑誌. 2023. 114. 2. 61-65
-
市川 孝治, 白石 裕雅, 徳永 素, 和田里 章悟, 窪田 理沙, 久住 倫宏, 津島 知靖. 腹腔鏡下副腎摘除術後の退院日に影響する因子は何か 単一術者によるコホートでの検討(What factors influence discharge date after laparoscopic adrenalectomy?: A study in a single-surgeon cohort). 日本泌尿器科学会総会. 2023. 110回. AOP08-02
-
徳永 素, 白石 裕雅, 和田里 章悟, 窪田 理沙, 久住 倫宏, 市川 孝治, 津島 知靖. 根治的膀胱全摘術におけるGeriatric Nutritional Risk Indexによる周術期合併症並びに予後予測の検討(Perioperative complications and prognosis prediction by Geriatric Nutritional Risk Index in radical cystectomy). 日本泌尿器科学会総会. 2023. 110回. PP12-03
ｍore...
Return to Previous Page
